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This report describes the clinical and histologic recovery of a 2-year-old mixed-breed dog pre-
sented with hypovolemic shock, markedly increased serum alanine amino transferase activity,
and hemoabdomen. Emergency exploratory surgery revealed a friable liver with multiple capsule
hemorrhages necessitating removal of the left lateral lobe. Histologic evaluation showed acute
massive hepatic necrosis with centrilobular and midzonal distribution. The dog survived, and all
monitored laboratory values normalized within 7 weeks. A liver biopsy taken 8 weeks after pre-
sentation revealed normal hepatic architecture with a few, randomly distributed neutrophilic
foci. Follow-up included intermittent determination of liver variables including liver function
tests for a period of 7 years. The dog's health status, and all test results remained normal during
this time. Complete recovery and good long-term quality of life after life-threatening acute liver
failure secondary to massive hepatic necrosis is possible in dogs.
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1 | CASE REPORT
A 2-year-old mixed-breed dog (male, neutered) weighing 10.8 kg
(23.8 lb) with a body condition score (BCS) of 5 out of 9 was admitted
to our clinic with a history of acute weakness and 1 episode of
vomiting. Approximately 8 hours before admission, the owner had
returned from a hike in the Alps where the dog was off-leash and was
seen playing briefly with mushrooms, although ingestion was not
observed. Physical examination showed hypothermia (rectal tempera-
ture, 35.1C [95F]), pale mucous membranes, a prolonged capillary
refill time of 3 seconds, weak femoral pulses, tachycardia, tachypnea,
and a painful abdomen. Systolic blood pressure was immeasurably
low. Laboratory analyses showed normochromic, normocytic anemia
(hematocrit 30%; reference range [RR] 42%-55%), hypoproteinemia
(32 g/L, RR 55-71 g/L), hypoalbuminemia (17 g/L, RR 29-37 g/L),
serum alanine amino transferase activity (ALT) activity greater than
the upper limit of detection (>6000 U/L, RR 20-93 U/L), and hyper-
lactacidemia (8.2 mmol/L, RR 0-2 mmol/L). Thoracic radiographs
showed a small cardiac silhouette and vena cava. Abdominal
radiographs showed loss of serosal detail and liver with normal size
and shape. Abdominal ultrasonography showed moderate amounts of
free abdominal fluid and a moderately hyperechoic liver parenchyma.
An activated clotting time (Hemochron 401 Analyzer; Soma
Technology, Inc, Bloomfield, CT) was prolonged at 223 seconds (RR,
60-125 seconds) with normal platelet count (236 000 platelets/μL,
RR 130000-400 000/μL). The results of abdominal fluid analysis
(hematocrit 37%, total protein 38 g/L) were compatible with acute
hemoabdomen. Volume replacement treatment with isotonic-lactated
Ringer's solution and colloids (6% hetastarch solution) was continu-
ously adjusted based on vital signs and blood pressure measurements.
After the 1st fluid resuscitation, the mean arterial pressure had
increased to 65 mm Hg and remained between approximately 60 and
70 mm Hg for the 1st 24 hours. The goal was to avoid overly aggres-
sive fluid administration as this was believed to further exacerbate
hemorrhage. Esomeprazole (1 mg/kg IV q12h; Esomep IV, Astra
Zeneca, Zug, Switzerland), ondasetron (0.2 mg/kg IV q12h; Labatec
Pharma, Meyrin, Switzerland), and vitamin K (2 mg/kg IV q12h;
Konakion MM, Roche Pharma, Switzerland) were also administered.
After 24 hours of treatment, the dog had a hematocrit of 12%,
Abbreviations: ALF, acute liver failure; ALT, alanine amino transferase activity;
aPTT, activated partial thromboplastin time; BCS, body condition score; HPC,
hepatic progenitor cells; PT, prothrombin time; RR, reference range.
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a refractometric total plasma protein concentration of 16 g/L, and a
platelet count of 51 000/μL. At this time, serum bilirubin concentra-
tion (11.7 μmol/L; RR 0-3.5 μmol/L) and alkaline phosphatase (ALP)
activity (87 U/L; RR 20-98 U/L) were also measured. Alanine amino
transferase activity was 6799 U/L (RR 20-93 U/L). Administration of
200 mL fresh frozen plasma and 150 mL packed red blood cells led to
increases in the hematocrit (25%) and total plasma protein concentra-
tion (32 g/L). Capillary blood glucose was continuously assessed and
remained within the RR (4-6 mmol/L). After 36 hours of treatment,
the hematocrit and total plasma protein concentration had again
decreased to 12% and 20 g/L, respectively, and an exploratory celiot-
omy was elected. Coagulation status was reevaluated and showed a
prolonged prothrombin time (PT) at 25.6 seconds (RR, 6.3-8.5 sec-
onds) and activated partial thromboplastin time (aPTT) at 24.1 seconds
(RR, 9.6-16.1 seconds), and the platelet count remained low at
29000/μL. A 2nd transfusion of fresh frozen plasma (200 mL) was
administered. Intraoperatively, the liver was pale and friable with mul-
tiple small elongated hemorrhaging serosal fissures on all liver lobes. A
larger, approximately 6 mm, oozing hepatic capsular rupture on the
left lateral lobe was observed to increase in size with minimal pres-
sure. Therefore, the left lateral lobe was removed using a stapling
device, and no further hemorrhage was seen. No other liver biopsies
were taken. Postoperatively, the dog developed generalized peripheral
edema, and therefore, 1 transfusion with human albumin (2 g/kg over
5 hours; Albumin CSL 20%, CSL Behring AG, Bern, Switzerland) was
administered. Twenty-four hours after surgery, gradual clinical
improvement was noted, and the dog started to eat small amount of a
highly digestable diet when hand-fed. Serum bilirubin concentration
and ALP activity had risen to 37.7 μmol/L (RR, 0-3.5 μmol/L) and
183 U/L (RR, 20-98 U/L), whereas ALT activity had decreased to
2365 U/L (RR, 20-93 U/L) (Supporting Information Table 2). Support-
ive treatment in addition to fluid therapy, ondansetron, and esomepra-
zole consisted of amoxicillin (20 mg/kg IV q8h; Clamoxyl 1 g,
GlaxoSmithKline, Switzerland), S-adenosylmethionine (450 mg PO
q24 h; Denosyl 225 mg, Nutramax, Edgewood, MD), and ursodeoxy-
cholic acid (15 mg/kg PO q24h; De-Ursil, CPS Cito Pharma, Uster,
Switzerland).
Histologic examination showed a zonal distribution pattern of
massive coagulative necrosis that affected all liver lobules. The necro-
sis extended from the centrilobular regions over the midzonal area to
the portal fields, sparing only a small rim of hepatocytes around the
portal triad and limiting plate (Figures 1 and 2). Necrotic hepatocytes
were characterized by hyperesinophilic cytoplasm and loss of nuclei.
Necrotic areas were sharply demarcated from the remaining viable tis-
sue. In the adjacent parenchyma, sinusoids appeared markedly con-
gested with multifocal leukocytostasis without neutrophilic infiltration
of the parenchyma. The diagnosis was massive acute hepatic necrosis.
The dog continued to improve clinically and was discharged on
day 6 after surgery. By the time of discharge, the hematocrit had
increased to 24% with an adequate regenerative response, serum pro-
tein concentration was nearly normal, and ALT activity had decreased
to 1917 U/L (Supporting Information Tables 1 and 2). The owner was
advised to continue administering amoxicillin and omeprazole for
1 week and S-adenosylmethionine and ursodeoxycholic acid for
another 6 weeks.
At the 1st reexamination 1 week after discharge, clinical abnor-
malities included a higher sleep requirement than normal and pale pink
mucous membranes. The hematocrit had increased to 34%, ALT activ-
ity had substantially decreased to 308 U/L, serum bilirubin concentra-
tion had decreased to 4.5 μmol/L (0-3.5 μmol/L), and ALP activity had
normalized (Supporting Information Table 3). The dog was clinically
normal at the 2nd reexamination 3 weeks after discharge, and the
only laboratory abnormality was mild anemia (Supporting Information
Table 3). The results of all laboratory tests were normal at the 3rd
reexamination 7 weeks after discharge. Ultrasonography of the liver
showed mildly heterogeneous parenchymal echogenicity. At this
point, the benefit of follow-up histologic examination of the liver to
assess hepatic regeneration (restitutio ad integrum versus progression
to chronic changes)1 was discussed, and collection of liver biopsy
specimens was planned for the next day. Coagulation times (PT, aPTT)
FIGURE 1 Liver, ruptured left lateral lobe. Hematoxylin and eosin
staining: Acute panlobular necrosis with surviving periportal
hepatocytes. The necrosis is sharply demarcated, and the sinusoids
are congested
FIGURE 2 Liver, ruptured left lateral lobe. Hematoxylin and eosin
staining: Acute panlobular necrosis with surviving periportal
hepatocytes between 2 portal fields
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were normal, and 2 ultrasound-guided percutaneous Tru-Cut liver
biopsy specimens (16 gauge needle) were obtained under brief propo-
fol anesthesia from the right lateral lobe.
Histologically, the hepatic architecture was regularly distributed,
and the distance from the central vein to the portal field was normal.
The hepatocytes appeared normal in size and morphology with no
increase in intracytoplasmic pigments. The spaces of Disse and the
bile canaliculi were not visible with hematoxylin and eosin stain
(Figure 3). Multifocal aggregates of macrophages with yellowish
brown intracytoplasmic pigment (lipofuscin) (Figure 4) were seen in
small numbers within the parenchyma. Isolated neutrophils were seen
at the interface of the limiting plate and portal tracts (Figure 4). There
was no evidence of scar tissue, regenerative nodules, or noticeable
progression toward chronic hepatitis. Even distribution of a very fine
network of reticulin fibers between the hepatocytes was seen in all
hepatic lobules (Figure 5). This network was interpreted as normal.
The mild neutrophilic infiltration and aggregates of macrophages with
intracytoplasmic lipofuscin were interpreted as a remnant reparative
process after acute liver injury.
Follow-up telephone calls for the next several years indicated that
the dog was normal and active. A general health checkup 5 years after
initial treatment showed no abnormalities on physical examination
with a BCS of 5 out of 9 (11.8 kg, [26 lb]). Results of a CBC, serum
biochemistry panel, and urinalysis were all normal (Supporting Infor-
mation Table 3). Liver function testing consisting of preprandial and
postprandial serum bile acid concentration as well as plasma ammo-
nium concentration was normal. The radiographic liver size based on
gastric axis position was slightly smaller than normal; however, it was
unclear whether this was because of lobectomy or fibrosis. Hepatic
ultrasonography was not done because of its low sensitivity and spec-
ificity for detection of parenchymal abnormalities.2,3 At the time of
manuscript preparation (7 years after initial presentation), the dog is
still in excellent health. Results of routine predental laboratory testing
(CBC, serum biochemistry panel) were all normal (Supporting Informa-
tion Table 3).
2 | DISCUSSION
This case report is noteworthy because it provides veterinarians with
information on the histologic and clinical long-term recovery of a dog
with acute liver failure (ALF) caused by massive hepatic necrosis.
Information such as this is invaluable for providing owners with the
possibility for a positive long-term outcome.
In dogs, ALF is defined as the development of acute clinical signs
with concurrent hyperbilirubinemia and coagulopathy.4 Because of
FIGURE 3 Tru-Cut biopsy taken 8 weeks after initial presentation.
Hematoxylin and eosin staining: Normal liver architecture,
hepatocytes show normal morphology, the portal field contains an
unaltered bile duct, normally sized portal vein, and normal artery.
There is minimal periportal neutrophilic infiltration
FIGURE 4 Tru-Cut biopsy taken 8 weeks after initial presentation.
Hematoxylin and eosin staining: Minimal periportal inflammation
consisting of neutrophils, small clusters of macrophages with
intracytoplasmic yellow to gold brown pigment (lipofuscin, arrow), and
residual degeneration. In the adjacent liver parenchyma at the limiting
plate small cluster of neutrophils (asterisk)
FIGURE 5 Tru-Cut biopsy taken 8 weeks after initial presentation.
Reticulin staining: Reticulin fibers represented by a fine network of
fibers between hepatocytes. The amount of reticulin fibers around
portal fields, central vein, and in the midzone of hepatic lobules was
deemed normal
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the fulminant course of the disease, ALF is mainly a clinical diagnosis
because obtaining hepatic biopsy specimens is considered a life-
threatening procedure. In the present case, uncontrollable hepatic
hemorrhage necessitating emergency exploratory surgery enabled col-
lection of liver specimen for histologic examination. In retrospect, this
surgical intervention appears curative, but at the time, we considered
it a last resort and the owner was given a grave prognosis. It proved
challenging when discussing the prognosis with the owner because of
the lack of information available for estimating possible survival and
long-term outcomes in dogs with ALF.
Different patterns of hepatocellular necrosis can be distinguished
histologically and comprise focal or multifocal, randomly distributed
necrosis, piecemeal necrosis, zonal necrosis, and lobular necrosis.5
Lobular necrosis can further be subdivided into centrilobular, peripor-
tal, and panlobular (massive) necrosis.5 Focal or multifocal necrosis
with a random distribution occurs in hematogenous infections, and
centrilobular necrosis is a common sequela of intoxications6–9 and
hypoxia;5 however, it occurs in certain viral infections (adenovirus 1)
of dogs.10 Some intoxications can cause only midzonal necrosis or
periportal necrosis; however, this is rather uncommon.5
Acute liver failure in dogs has been associated with toxins and
toxicants,6–9,11 drugs,12–15 neoplasia,4 and infection.7,16 In a recent
study of 49 dogs with ALF, the cause was identified in roughly one
third and comprised neoplasia, presumptive leptospirosis, and ische-
mia.4 The remaining two thirds were deemed idiopathic although
exposure to hepatotoxins and toxicants was frequently suspected.4
In the present case, exposure to hepatotoxic mushrooms (Amanita
spp.) was suspected but could not be verified. Although histologic
lesions are not specific or pathognomonic for a single toxin/toxicant,
the histologic findings in our case were similar to lesions described in
proven amanitin toxicosis in dogs7 and cats.5 Clinical signs of amanitin
toxicosis, consisting of fulminant multi-organ failure including liver
and less commonly kidneys, become apparent approximately
36-84 hours after exposure to amanitins.17 The time course and
severity of clinical signs depend on the ingested dose, and death can
ensue within 24 hours of ingesting large doses of amatinins in dogs.18
Although select veterinary toxicology laboratories provide amanitin
testing, there is unfortunately no retrospective method to detect ama-
nitin toxin, and a definitive diagnosis requires examining fresh liver tis-
sue or urine specimens.9
A vascular incident leading to ischemic necrosis was also initially
considered. However, evidence of vascular infarction or thromboem-
bolism was not found at surgery, and diseases known to predispose to
thromboembolism were not identified.
To our knowledge, there is no information on the results of
follow-up assessment of dogs that survive ALF caused by massive
liver necrosis. In the largest study on canine ALF, 7 of the 49 (14.3%)
dogs survived to the time of discharge, but no follow-up data were
given.4 Follow-up information was also not provided in a recent study
describing dogs with food-borne hepatic aflatoxicosis.11 There are
2 reports that include follow-up information on dogs that survived
ALF based on clinical results.8,9 One of the cases was a dog with ALF
caused by ingestion of blue-green algae (Microcystis spp.), and follow-
up information was limited to 12 days.9 The 2nd case report on a dog
with ALF because of xylitol ingestion included clinical and clinicopath-
ologic information for 7 months after the initial toxicosis.8
Histologic reassessment of liver biopsy specimens in the present
case showed complete restoration of the hepatic architecture.
Although a plethora of experimental data on hepatic regeneration in
dogs exists in the literature19 that might also be extrapolated to
regenerative responses after massive necrosis, to our knowledge,
there is no information regarding hepatic regeneration after acute
hepatic necrosis in dogs. Available information focuses on
carbon-tetrachloride-induced hepatic necrosis (administered over the
course of 14-20 days),20 and results suggest that histologic evidence
of moderate necrosis and destruction of normal lobular architecture is
still present 8 weeks after induction of necrosis.20
Based on observations of young people with ALF, it has been pro-
posed that a high proportion of surviving hepatocytes within necrotic
parenchyma is not a prerequisite for native liver regeneration.21
In cases of complete hepatocyte regeneration, necrosis of up to 80% of
the liver cell mass in resected native liver has been described.21 In the
course of hepatocyte regeneration after massive hepatic necrosis, duct-
ular cell proliferation plays an important role. These so-called “ductular
reactions” composed of hepatic progenitor cells (HPC) probably ema-
nate from the canals of Hering, located close to the limiting plate.22 In
human hepatology, massive hepatocyte loss caused by viral infections
or ingestion of toxic substances triggers an HPC response within
24 hours and a prominent ductular reaction can be observed. Prolifera-
tion is followed by differentiation, during which the ductular reactions
give rise to “hepatocyte-like cells” also identified as intermediate hepa-
tocytes.23 In dogs, the involvement of the HPC compartment has also
been described in acute hepatitis.23 A ductular reaction has been
observed localized to the site of injury, accompanied by intermediate
cells.24 Later, these cells then decrease in number and subsequently
complete differentiation into hepatocytes.25 In humans, sequential his-
tologic evaluation after massive hepatic necrosis because of fulminant
viral hepatitis B infection showed that liver cell regeneration started
with proliferation of HPC at 7-10 days after auxiliary partial orthotopic
liver transplantation.26 Hepatocyte differentiation of HPC occurred
close to 1 month after transplantation. At 2 months, there was no evi-
dence of necrosis, ductules decreased in number, and numerous indi-
vidual hepatocytes appeared in the native liver.26
The hepatic regenerative process in our case appeared rapid and
extensive. At 8 weeks, there was no histologic evidence of embryonic
ductule buds, and only fully developed hepatocytes, lobules, and
portal triads were seen. We also found it remarkable that such marked
panlobular necrosis was followed by complete regeneration without
evidence of fibrotic changes. The scattered foci of neutrophilic
infiltration were believed to reflect a remnant reparative response.
Concurrent normalization of liver enzyme activities and indirect liver
function variables further supported the theory of a rapid healing
response. The 2nd histologic evaluation did not strictly reflect the
regenerative response to the initial insult of necrosis because the
most severely affected hemorrhaging lobe had been removed. A limi-
tation of this case report is the lack of biopsies from additional liver
lobes; however, it was assumed that the disease process was affecting
the entire liver based on the gross appearance during surgery.
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In addition to factors such as the etiology of the disease and results
of clinical and laboratory testing, the time chosen for re-biopsy of the
liver is likely crucial for detecting the development of chronic changes.
Our decision was based on work by Poldervaart et al who reported that
a fraction (5/12 repeatedly sampled dogs) of dogs with acute hepatitis
went on to develop chronic hepatic disease.1 The authors suggested
that early recognition and treatment with corticosteroids are of key
importance for prevention of disease progression and increased survival
time. It is difficult to compare our case to results of that study as details
on the severity of necroinflammatory lesions in the repeatedly sampled
dogs with “acute hepatitis” were not provided. In that study, dogs with
“severe acute hepatitis” died, and the remaining acute hepatitis cases
that underwent a 2nd liver biopsy 6 weeks later very likely represented
disease entities that differed from our case.1 We ultimately decided to
refrain from treatment with corticosteroids because the amount of reti-
culin fibers was deemed normal. In addition, the owner did not want to
pursue collection of further liver biopsy specimens for assessment of
the degree of hepatic fibrosis.
In summary, this case report describes complete and long-term
recovery from life-threatening ALF caused by massive hepatic necro-
sis in a dog. Potential later subclinical chronic hepatic remodeling did
not affect quality of life and was not evident based on the results of
routine liver function testing. Even if the etiology remains unknown
and the presented outcome might not be transferrable to other types
of hepatic necrosis or ALF, this case report serves as a valuable refer-
ence for veterinarians who need information to base their decisions
when dealing with similar cases. It is important to recognize that long-
term survival with adequate hepatic regeneration and a good quality
of life is possible even in severe cases of ALF.
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